Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Outcomes in Patients With Non–small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.10.017Source: DataRank Database

Outcomes in Patients With Non–small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy is a research paper published in Clinical Lung Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)OA: bronzeTopics (23)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Christiana Davis,Wei‐Ting Hwang ORCID,Seth Jeffries ORCID,Lydia Frenzel Sulyok,Melina E. Marmarelis ORCID

Live enrichment

PubMed:33279417

National Institutes of Health

Grant: T32CA009679

Boehringer Ingelheim

Amgen

Merck Sharp and Dohme

Merck

GlaxoSmithKline

Novartis

Eli Lilly and Company

Gilead Sciences

Incyte

AstraZeneca

Bristol-Myers Squibb

Takeda Pharmaceutical Company

bronzeLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttp://www.clinical-lung-cancer.com/article/S1525730420303272/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1525730420303272?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525730420303272?httpAccept=text/plain

MeSH Terms

HumansCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellBrain NeoplasmsLung NeoplasmsLymphatic MetastasisAntineoplastic Combined Chemotherapy ProtocolsPrognosisSurvival RateRetrospective StudiesFollow-Up StudiesAgedMiddle AgedFemaleMaleAntibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalAdenocarcinoma of Lung

Keywords

Lung cancerImmunotherapyBrain metastasesCranial IrradiationPembrolizumab